Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 121 to 126 of 126 results for thyroid* OR hypothyroid* OR Hyperthyroid* OR goiter

  1. What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for people with T3 thyrotoxicosis due to Graves' disease?

    applicable) Source guidance details Comes from guidance Thyroid disease: assessment and management Number NG145 Date issued

    Research recommendation
    Published
    10 February 2020

  2. Further research should report details of patient selection, nodule size and position, and whether the nodule is cystic.

    the safety of high-intensity focused ultrasound for symptomatic benign thyroid nodules raises no major safety concerns, however the...

    Research recommendation
    Published
    19 March 2019

  3. Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]

    Discontinued [GID-HST10038]

    Highly specialised technologies guidance
    Discontinued

  4. Pralsetinib for thyroid cancer [ID4018]

    In development [GID-TA10910] Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]

    In development [GID-TA10555] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Helping GPs make an early diagnosis of cancer

    Thousands of lives in England could be saved each year if the NHS follows updated guidance to help it diagnose cancer earlier. Here we outline what the guidance means for GPs.

    News
    Published
    23 June 2015